148 related articles for article (PubMed ID: 26171487)
1. [Current state and potential of pharmacogenetic studies in the treatment of depression].
Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487
[TBL] [Abstract][Full Text] [Related]
2. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
Schosser A; Kasper S
Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
[TBL] [Abstract][Full Text] [Related]
3. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
Gardier AM
Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
[TBL] [Abstract][Full Text] [Related]
4. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
Fabbri C; Porcelli S; Serretti A
Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of depression: the current state and perspectives of the development of pharmacological studies].
Ivanetz NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):108-16. PubMed ID: 25614913
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of antidepressant response.
Keers R; Aitchison KJ
Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics of depression in elderly patients].
Monnin J; Haffen E; Sechter D; Vandel P
Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic insights into depression and antidepressant response: does sex matter?
Pitychoutis PM; Zisaki A; Dalla C; Papadopoulou-Daifoti Z
Curr Pharm Des; 2010; 16(20):2214-23. PubMed ID: 20459391
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of antidepressant drugs.
Horstmann S; Binder EB
Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in the treatment of depression: pharmacodynamic studies.
Serretti A; Artioli P; Quartesan R
Pharmacogenet Genomics; 2005 Feb; 15(2):61-7. PubMed ID: 15861029
[TBL] [Abstract][Full Text] [Related]
12. The role of dopamine and norepinephrine in depression and antidepressant treatment.
Nutt DJ
J Clin Psychiatry; 2006; 67 Suppl 6():3-8. PubMed ID: 16848670
[TBL] [Abstract][Full Text] [Related]
13. [Development of newer antidepressant].
Inada K
Nihon Rinsho; 2007 Sep; 65(9):1645-9. PubMed ID: 17876988
[TBL] [Abstract][Full Text] [Related]
14. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment.
Bukh JD; Bock C; Vinberg M; Werge T; Gether U; Kessing LV
Eur Neuropsychopharmacol; 2010 May; 20(5):327-35. PubMed ID: 20022223
[TBL] [Abstract][Full Text] [Related]
15. Novel agents in development for the treatment of depression.
Grady MM; Stahl SM
CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
[TBL] [Abstract][Full Text] [Related]
16. The pharmacogenetics of depression: enter the GWAS.
Malhotra AK
Am J Psychiatry; 2010 May; 167(5):493-5. PubMed ID: 20439394
[No Abstract] [Full Text] [Related]
17. Pharmacogenomics and antidepressant drugs.
Binder EB; Holsboer F
Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694
[TBL] [Abstract][Full Text] [Related]
18. Plant-derived natural medicines for the management of depression: an overview of mechanisms of action.
Farahani MS; Bahramsoltani R; Farzaei MH; Abdollahi M; Rahimi R
Rev Neurosci; 2015; 26(3):305-21. PubMed ID: 25719303
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic response to antidepressants in a multicase family with affective disorder.
O'Reilly RL; Bogue L; Singh SM
Biol Psychiatry; 1994 Oct; 36(7):467-71. PubMed ID: 7811843
[TBL] [Abstract][Full Text] [Related]
20. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
